. Author manuscript; available in PMC: 2022 Jan 4.

Published in final edited form as: Nutr Cancer. 2020 Dec 15;73(11-12):2740–2750. doi: 10.1080/01635581.2020.1857412

Table 5:

Urinary concentrations of tocopherol metabolites (μM) before and after supplementation.

Group		α-CEHC	γ-CEHC	δ-CEHC	α-CMBHC	γ-CMBHC	δ-CMBHC
Control n=12	Pre	0.22 ± 0.42	15.38 ± 15.62	13.72 ± 12.26	0.34 ± 0.64	4.71 ± 4.30	4.59 ± 4.55
Control n=12	Post	0.74 ± 1.14	9.78 ± 6.48	8.65 ± 6.70	0.11 ± 0.26	4.45 ± 3.23	5.18 ± 6.29
1-week n=12	Pre	0.67 ± 1.16	19.02 ± 14.28	12.66 ± 10.33	0.16 ± 0.39	5.28 ± 5.35	3.36 ± 3.03
1-week n=12	Post	6.76 ± 13.15	134.67^b ± 106.81	84.93^b ± 61.51	1.42 ± 1.67	44.87^c ± 44.57	44.17^b ± 32.63
2-week n=13	Pre	0.47 ± 1.22	10.75 ±11.56	7.40 ± 5.75	0.16 ± 0.24	2.90 ± 4.09	2.33 ± 2.13
2-week n=13	Post	8.78 ± 13.61	128.82^b ± 101.77	94.38^b ± 50.64	4.57^a ± 8.05	55.23^a ± 82.09	43.69^b ± 30.63

Data are expressed as mean ± standard deviation. Pre-post differences were compared to the control group by pair-wise comparisons using parametric t-test analyses (P < 0.05^a, P < 0.005^b) and non-parametric analyses (P < 0.05^c).